What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?

Gary S. Francis; John P. Gassler

doi:10.3949/ccjm.68.3.185

What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?

Gary S. Francis, John P. Gassler

Medicine - Cardiology Division

Research output: Contribution to journal › Short survey › peer-review

3 Scopus citations

Abstract

Improvement in surrogate end points may not necessarily translate into improvement in "hard" clinical end points.

Original language	English (US)
Pages (from-to)	185-186
Number of pages	2
Journal	Cleveland Clinic journal of medicine
Volume	68
Issue number	3
DOIs	https://doi.org/10.3949/ccjm.68.3.185
State	Published - Jan 1 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.3949/ccjm.68.3.185

Find It

Find It at U of M Libraries

Cite this

@article{eaeb5cc07596498e8e6a20bb849068d4,

title = "What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?",

abstract = "Improvement in surrogate end points may not necessarily translate into improvement in {"}hard{"} clinical end points.",

author = "Francis, {Gary S.} and Gassler, {John P.}",

year = "2001",

month = jan,

day = "1",

doi = "10.3949/ccjm.68.3.185",

language = "English (US)",

volume = "68",

pages = "185--186",

journal = "Cleveland Clinic journal of medicine",

issn = "0891-1150",